help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ka, H.
Right arrow Articles by Bazer, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ka, H.
Right arrow Articles by Bazer, F. W.
Endocrinology Vol. 142, No. 6 2303-2310
Copyright © 2001 by The Endocrine Society


ARTICLES

Keratinocyte Growth Factor Is Up-Regulated by Estrogen in the Porcine Uterine Endometrium and Functions in Trophectoderm Cell Proliferation and Differentiation1

Hakhyun Ka, Laurie A. Jaeger, Greg A. Johnson2, Thomas E. Spencer and Fuller W. Bazer

Center for Animal Biotechnology and Genomics (H.K., L.A.J., G.A.J., T.E.S., F.W.B.) and Departments of Animal Science (H.K., G.A.J., T.E.S., F.W.B.) and Veterinary Anatomy and Public Health (L.A.J.), Texas A&M University, College Station, Texas 77843-2471

Address all correspondence and requests for reprints to: Dr. Fuller W. Bazer, Department of Animal Science and Center for Animal Biotechnology and Genomics, 442D Kleberg Center, Texas A&M University, College Station, Texas 77843-2471. E-mail: fbazer{at}cvm.tamu.edu


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Keratinocyte growth factor (KGF) is expressed by uterine endometrial epithelial cells during the estrous cycle and during pregnancy in pigs, whereas KGF receptor is expressed in conceptus trophectoderm and endometrial epithelia. In particular, KGF expression in the endometrium is highest on day 12 of pregnancy. This corresponds to the period of maternal recognition of pregnancy in pigs, which is signaled by large amounts of estrogen secreted by conceptus trophectoderm acting on the endometrium. Our hypothesis is that estrogens of conceptus origin stimulate endometrial epithelial KGF expression, and, in turn, secreted KGF stimulates proliferation and differentiation of conceptus trophectoderm. To determine the factors affecting KGF expression in the uterus, endometrial explants from gilts on day 9 of the estrous cycle were cultured in the presence of 17ß-estradiol, catechol estrogens, or progesterone. 17ß-Estradiol stimulated the expression of KGF (P < 0.05), whereas catechol estrogens had no effect (P > 0.05). Between days 9 and 15 of pregnancy, proliferating cell nuclear antigen was abundant in conceptuses, but was barely detectable in uterine endometrial epithelia. To determine the effects of KGF on conceptus trophectoderm, porcine trophectoderm (pTr) cells were treated with recombinant rat KGF (rKGF). rKGF increased the proliferation of pTr cells (P < 0.01) as measured by [3H]thymidine incorporation. rKGF elicited phosphorylation of KGF receptor and activated the mitogen-activated protein kinase (ERK1/2) cascade in pTr cells. pTr cell differentiation was affected by rKGF, because it increased expression of urokinase-type plasminogen activator, a marker for differentiation in pTr cells. Collectively, these results indicate that estrogen, the pregnancy recognition signal from the conceptus in pigs, increases uterine epithelial KGF expression, and, in turn, KGF stimulates the proliferation and differentiation of conceptus trophectoderm.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
KERATINOCYTE GROWTH factor/fibroblast growth factor-7 (KGF/FGF-7), is a paracrine mediator of epithelial-mesenchymal interactions in various organs, including those of the reproductive tract (1, 2). The receptor for KGF (KGFR), which is also called FGF receptor 2IIIb (FGFR2IIIb), is an alternative splice variant of the bek gene product and is present only on epithelial cells. KGF is expressed in ovary, uterus, prostate, and mammary gland, and uterine expression of KGF has been identified in several species, including humans, primates, rodents, and sheep (2, 3). In these species, mesenchymal expression of KGF and epithelial expression of KGFR suggested that KGF is a stromal cell-derived paracrine mediator of epithelial-mesenchymal interactions in the uterus. In the pig, however, KGF is expressed in the uterine endometrial epithelia and secreted into the uterine lumen, whereas the KGFR is expressed in both endometrial epithelia and conceptus trophectoderm (4). These findings suggest that in the pig, which is the only species possessing a true epitheliochorial type of placentation, KGF may play a role in paracrine epithelial-epithelial interactions between conceptus and uterus during early pregnancy (4).

In the pig, KGF expression in the endometrium is highest on day 12 of pregnancy during the period of maternal recognition of pregnancy (4). In male and female reproductive organs, KGF gene expression in rodents is up-regulated by steroid hormones such as androgens, estrogen, and progesterone (P4). The KGF gene has an androgen response element in the promoter region (5), and testosterone increased the expression of KGF in prostate and seminal vesicles (6, 7). In primate endometrium, P4 increases KGF expression during the luteal phase, suggesting that KGF is a mediator of P4 action on epithelial cells or a progestamedin (8). It has also been suggested that KGF is induced by estrogen in the female genital tract of mice during neonatal development (9). 17ß-Estradiol (E2) treatment in vivo increases KGF messenger RNA (mRNA) and protein expression in the mouse mammary gland (10). In the porcine uterus, estrogens are secreted by conceptus trophectoderm beginning on days 11 and 12 of pregnancy and are the signal for maternal recognition of pregnancy (11). Progesterone levels also increase up to 30 ng/ml in plasma during early pregnancy (12). Therefore, estrogens and/or P4 may be responsible for the increased KGF expression in the porcine uterine endometrium during early pregnancy.

During early pregnancy, pig conceptuses undergo dramatic changes in morphology and differentiation in preparation for implantation and placentation (13, 14). It is well known that KGF stimulates the proliferation and migration of various epithelia and also affects cellular differentiation processes (1). The biological activity of KGF is achieved through intracellular signaling activated by KGFR, and KGF activates phosphorylation of KGFR and the mitogen-activated protein kinase (MAPK) pathway (15). Given that KGF is a component of histotroph, it may stimulate the proliferation and differentiation of the conceptus. Therefore, the objectives of this study were to determine: 1) the effects of estrogens and P4 on KGF expression in the porcine uterine endometrium, and 2) the effects of KGF on proliferation and differentiation of porcine conceptus trophectoderm in vitro.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals and tissue collection
Experimental and surgical procedures involving animals were approved by the agricultural animal care and use committee of Texas A&M University (Animal Use Protocol 2000–120). Sexually mature, cross-bred gilts were observed daily for estrous behavior and were either bred or allowed to continue cycling. For endometrial explant culture, gilts (n = 3) were hysterectomized on day 9 postestrus, and uteri were transported on ice directly to the laboratory and processed. For collection of cyclic and pregnant endometrium, gilts (n = 3 gilts/day) were hysterectomized on days 9, 12, and 15 of the estrous cycle and on days 9, 10, 12, 15, 30, and 60 of pregnancy as described previously (16). Conceptuses from days 9, 12, and 15 of pregnancy were obtained at hysterectomy by flushing the uterine horns with 40 ml Hanks’ Balanced Salt Solution (Sigma, St. Louis, MO). Tissue samples for paraffin sections were fixed in 4% paraformaldehyde in PBS (pH 7.2) as described previously (16).

Explant culture
Endometrium was dissected from myometrium and placed into warm phenol red-free DMEM/F-12 culture medium (DMEM/F-12; Sigma) containing penicillin G (100 IU/ml), streptomycin (0.1 mg/ml), and amphotericin (0.25 µg/ml; Life Technologies, Inc., Grand Island, NY), as described previously (17). Endometrium was then minced with scalpel blades into small pieces (2–3 mm3), and aliquots of 500 mg were placed into culture dishes (100 x 15 mm) with serum-free modified DMEM/F-12 containing 10 µg/ml insulin (Sigma, catalogue no. I5500), 10 µg/ml transferrin (Sigma, catalogue no. T1428), and 10 ng/ml hydrocortisone (Sigma, catalogue H0396). Endometrial explants were cultured immediately after mincing in the presence of E2 (0, 0.05, 0.5, 5, and 50 ng/ml), P4 (0, 0.03, 0.3, 3, and 30 ng/ml), catechol estrogens [5 ng/ml 2-hydroxy-E2 (2OH-E2) or 5 ng/ml 4OH-E2], estrogen receptor (ER) antagonist [50 ng/ml ICI 182,780 (ICI)], or E2 (5 ng/ml) plus P4 (3 ng/ml) for 48 h with rocking under an atmosphere of 45% nitrogen, 5% carbon dioxide, and 50% oxygen. E2 (catalogue no. E8875), P4 (catalogue no. P0130), 2OH-E2 (catalogue no. H3131), and 4OH-E2 (catalogue no. H4637) were obtained from Sigma, and ICI was purchased from Tocris (Ballwin, MO). Explant tissues were then harvested, and RNA was extracted for slot blot analysis of KGF expression. These experiments were conducted using endometrium from three individual gilts. Treatments were performed in triplicate using tissues obtained from each gilt.

Porcine trophectoderm cells
Porcine trophectoderm cells were isolated using nonenzymatic dispersion of trophoblast from conceptuses collected on day 12 of gestation (18). A trophectoderm cell line (pTr) was established by repeated passage and culture of the cells on Primaria tissue culture plastic (Falcon, Lincoln Park, NJ). Cells were maintained in DMEM/F-12 containing 5% charcoal-stripped serum, antibiotics, 2 mM glutamine (Sigma), and 0.1 U/ml bovine insulin (Sigma).

[3H]Thymidine incorporation assay
Effect of KGF on proliferation of pTr cells was determined as described previously (19). Briefly, pTr cells were plated at 20,000 cells/cm2 in DMEM/F-12 containing 5% FBS, then serum-starved for 24 h in serum-free DMEM/F-12, containing 2 mM glutamine and 0.1% BSA. Cells were then treated with recombinant rat KGF (rKGF; 0, 1, 10, or 100 ng/ml) for 24 h at 37C in serum-free DMEM/F-12 containing 5 µCi/ml [3H]thymidine, precipitated in 10% trichloroacetic acid for 30 min on ice, and fixed in cold methanol. The fixed cells were solubilized in 0.6 ml 0.05% trypsin/0.1% SDS for 30 min at 37 C. [3H]Thymidine incorporation was counted using an LS 3801 liquid scintillation counter (Beckman Coulter, Inc., Palo Alto, CA). The total DNA content was determined using Picogreen (Molecular Probes, Inc., Eugene, OR) as described by the manufacturer. Data are expressed as disintegrations per min/µg total DNA.

Northern and slot blot hybridization analysis
Total cellular RNA was isolated from endometrial explant tissues and cultured pTr cells using TRIzol reagent (Life Technologies, Inc.). Expression of KGF in explant tissues and of urokinase-type plasminogen activator (uPA) in pTr cells was determined by Northern blot and slot blot hybridization analyses as described previously (16). Twenty micrograms of total cellular RNA were hybridized with 32P-radiolabeled antisense complementary RNA probes generated against a linearized 690-bp porcine KGF partial complementary DNA (cDNA) (4), 511 bp bovine uPA partial cDNA (provided by Dr. A. R. Menino, Jr., Oregon State University, Corvallis, OR), or 18S ribosomal RNA (pT718S, Ambion, Inc., Austin, TX). Autoradiographs of Northern blots to determine the size of the uPA transcript were prepared using Kodak X-OMAT x-ray film (Eastman Kodak Co., Rochester, NY). The radioactivity in each slot was quantified using a Packard Instant Imager (Packard, Meriden, CT) and is expressed as total counts.

RT-PCR
Expression of KGFR and interferon-{delta} (IFN{delta}) by pTr was determined by RT-PCR as described previously (20). Five micrograms of total RNA from pTr cells were reverse transcribed to obtain cDNAs using Superscript II reverse transcriptase (Life Technologies, Inc.). Newly synthesized cDNA was acid-ethanol precipitated, resuspended in 20 µl water, and stored at -20 C. The cDNAs were then diluted (1:10) with sterile water, and templates were amplified by PCR using AmpliTaq DNA polymerase (Perkin-Elmer Corp., Foster City, CA) and specific primers based on the human KGFR (GenBank accession no. M80637; forward, 5'-TCTGTTCAATGTGACCGAGG; reverse, 5'-GTTTTGGCAGGACAGTGAGC) or the porcine IFN{delta} (GenBank accession no. Z22706; forward, 5'-ATGGATTGTCCCCATGTAGG; reverse, 5'-CTGAGCTACCAGGGTTACCG). PCR conditions were 35 cycles of 95 C for 30 sec, 55 C for KGFR or 58 C for IFN{delta} for 30 sec, and 72 C for 1 min. PCR products (104 bp for KGFR and 296 bp for IFN{delta}) were separated in 2% agarose gels and visualized by ethidium bromide staining. The identity of each amplified PCR product was verified by sequence analysis after cloning into the pCRII vector (Invitrogen, Carlsbad, CA).

Immunohistochemistry
Expression of immunoreactive proliferating cell nuclear antigen (PCNA) was evaluated in conceptus and paraformaldehyde-fixed, paraffin-embedded, uterine tissue cross-sections (5 µm) using 2 µg/ml of a monoclonal antibody to PCNA (Santa Cruz Biotechnology, Inc., Santa Cruz, CA; catalogue no. sc-56) and a Super ABC Mouse IgG Kit (Biomeda, Foster City, CA), and procedures described previously (16). A boiling citrate buffer antigen retrieval protocol was used to reveal the PCNA according to the manufacturer’s recommendations. Purified normal mouse IgG (Sigma) at 2 µg/ml was substituted for mouse anti-PCNA and served as a negative control.

Immunofluorescence
The epithelial phenotype of pTr cells was confirmed using immunofluorescence microscopy as described previously (21). pTr cells were cultured in LabTek four-well chamber slides (Nunc, Naperville, IL), washed with PBS, fixed with methanol for 10 min at -20 C, air-dried, blocked in 5% normal goat serum, and incubated in primary antibody overnight at 4 C. Monoclonal antibodies to cytokeratin (hybridoma 8.13; 1:200 dilution) and vimentin (hybridoma V9; 1:200 dilution) were obtained from Sigma. Slides were then washed and incubated with fluorescein-conjugated rabbit antimouse IgG (1:200 dilution; Sigma) for 1 h at room temperature. After rinsing, all slides were overlaid with coverslips and Prolong antifade mounting reagent (Molecular Probes, Inc., Eugene, OR). Fluorescence images were recorded using a Carl Zeiss Axioplan 2 microscope fitted with a Hamamatsu C-5810 chilled three-color CCD camera (Carl Zeiss, Thornwood, NY) with Adobe Photoshop 5.0 (Adobe Systems, Seattle, WA) image capture software.

Immunoprecipitation and Western blot analyses
To confirm activation of the KGFR in vitro, pTr cells were treated with rKGF (10 ng/ml), and phosphorylation of the KGFR and the MAPKs, extracellular signal-regulated kinases 1 and 2 (ERK1/2), was assessed by immunoprecipitation and Western blot analysis. Briefly, monolayer cultures of pTr cells were grown to 75% confluence on 75-cm2 tissue culture flasks and then incubated in serum-free DMEM/F-12 containing 0.1% BSA for 48 h. Whole cell extracts were prepared as previously described (22). The protein concentration of the lysate supernatant was determined by Bradford assay (Bio-Rad Laboratories, Inc., Burlingame, CA) using BSA as the standard and 1 mg of each extract used for immunoprecipitation. Five micrograms of KGFR antibody (Santa Cruz Biotechnology, Inc., catalogue no. sc-122) or normal rabbit IgG were added to each extract, and bound proteins were purified using protein A/G plus agarose as described previously (22). Immunoprecipitated proteins were separated by SDS-PAGE and analyzed by Western blotting (as described below) with antibody to phosphotyrosine (Santa Cruz Biotechnology, Inc.; catalogue no. sc-7020) diluted 1:100 in 5% BSA-TBST (Tris-buffered saline/0.1% Tween-20).

In similar experiments pTr cells were serum-starved and treated with rKGF as described above. In addition to KGF treatment, some cells were pretreated with 0 or 50 µM of the MAPK/ERK kinase 1 (MEK1) inhibitor, PD98059 (New England Biolab, Beverly, MA; catalogue no. 9900L) for 1 h, then treated with 0 or 10 ng/ml rKGF for 60 min. Twenty micrograms of whole cell extract protein from each sample were separated by SDS-PAGE and transferred to nitrocellulose as described previously (21). Blots were blocked for 4 h at 4 C with either 5% BSA-TBST for phospho-specific antibodies or 5% nonfat milk-TBST for other antibodies, and then incubated with primary antibodies overnight at 4 C. Monoclonal antibodies to phospho-ERK1/2 (pERK1/2; 1:400 dilution in 5% BSA-TBST; catalogue no. sc-7383) and phospho-tyrosine (1:100 dilution in 5% BSA-TBST; catalogue no. sc-7020), and goat polyclonal antibody to ERK1/2 (1:400 dilution in 2% milk-TBST; catalogue no. sc-94-g) were obtained from Santa Cruz Biotechnology, Inc. Blots were then incubated with rabbit antigoat IgG or goat antimouse IgG conjugated to peroxidase (Kirkegaard & Perry Laboratories, Bethesda, MD) for 1 h at room temperature, and immunoreactive proteins were detected using enhanced chemiluminescence (Amersham Pharmacia Biotech, Arlington Heights, NY) according to the manufacturer’s recommendations.

Effect of KGF on pTr cell differentiation
To determine whether KGF affects functional cell differentiation, pTr cells were treated with increasing doses of rKGF (0, 1, 10, and 100 ng/ml) in serum-free DMEM/F-12 for 24 h. Expression of uPA was used as a marker for pTr cell differentiation by Northern and slot blot analyses.

Statistical analysis
All quantitative data were subjected to least squares ANOVA using the general linear models procedures of the Statistical Analysis System (SAS Institute, Inc., Cary, NC) (23). Data from dose-response studies on KGF and uPA expression were analyzed by least squares regression analysis. Slot blot data (total counts) were analyzed using the 18S ribosomal RNA data as a covariate to correct for differences in sample loading. Preplanned contrasts (control vs. E2 plus ICI; E2 vs. E2 plus ICI; control vs. catechol estrogens; control vs. E2; P4 vs. E2 plus P4) were used to test for effects of treatments in slot blot analyses. All tests of statistical significance were performed using the appropriate error terms according to the expectation of mean squares. Data are presented as least squares means with SEs.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Effects of estrogens on KGF expression
KGF expression was increased (quadratic, P < 0.05) by E2 (Fig. 1AGo). The increase in KGF expression by E2 was blocked by addition of the ER antagonist, ICI (Fig. 1BGo; E2 vs. E2 plus ICI, P < 0.05). Catechol estrogens, 2OH-E2 and 4OH-E2, did not affect KGF expression in endometrium (Fig. 1CGo; control vs. 2OH-E2 and control vs. 4OH-E2, P > 0.05).



View larger version (15K):
[in this window]
[in a new window]
 
Figure 1. Effect of estrogens on KGF mRNA expression in the porcine uterine endometrial explant cultures. A, Endometrial explants were cultured in DMEM/F-12 in the presence of E2 (0, 0.05, 0.5, 5, and 50 ng/ml) at 37 C for 48 h. KGF expression was affected by the dose of E2 (quadratic, P < 0.05). B, Endometrial explants were treated with a combination of E2 (5 ng/ml) and ICI (50 ng/ml) at 37 C for 48 h. Increased KGF expression produced by E2 (P < 0.01) was inhibited by ICI treatment. C, Endometrial explants were cultured in the absence or presence of E2 (5 ng/ml), 2OH-E2 (5 ng/ml), or 4OH-E2 (5 ng/ml) at 37 C for 48 h. E2 increased KGF expression (P < 0.01), but catechol estrogens did not affect KGF expression (P > 0.05). All experiments were repeated with endometrium from three individual gilts and in triplicate for each treatment using tissues obtained from each gilt.

 
Effects of P4 on KGF expression
Increasing doses of P4 decreased (quadratic, P = 0.07) KGF expression in the uterine endometrium (Fig. 2AGo). However, E2 increased (P < 0.01) KGF expression in both the absence and presence of P4 (Fig. 2BGo).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 2. Effect of P4 on KGF expression in porcine uterine endometrial explant cultures. A, Endometrial explants were cultured in DMEM/F-12 in the presence of P4 (0, 0.03, 0.3, 3, and 30 ng/ml) at 37 C for 48 h. KGF expression decreased with increasing dose of P4 (quadratic, P = 0.07). B, Endometrial explants were treated with a combination of E2 (5 ng/ml) and P4 (3 ng/ml) at 37 C for 48 h. E2 increased KGF mRNA expression (P < 0.01) when E2 alone or E2 plus P4 groups were compared with control or P4 alone groups, respectively. All experiments were repeated with endometrium from three individual gilts and in triplicate for each treatment using tissues obtained from each gilt.

 
PCNA protein expression
Immunoreactive PCNA protein was detected in nuclei of cells in the embryonic disc and in the trophectoderm (TE) near the embryonic disc of day 9 conceptuses (Fig. 3AGo). All TE cells of conceptuses recovered between days 10 and 15 of pregnancy expressed PCNA. In contrast, PCNA was not detected in endometrial luminal epithelium (LE) or glandular epithelium (GE) between days 9 and 12 of the estrous cycle or pregnancy. Although PCNA was barely detectable on day 15 of the estrous cycle and pregnancy, it was strongly detectable in LE and TE from days 30 and 60 of pregnancy, and was abundant in GE from day 60 of pregnancy (Fig. 3BGo).



View larger version (90K):
[in this window]
[in a new window]
 
Figure 3. Representative photomicrographs illustrating the distribution of immunoreactive PCNA protein in the conceptus (A) and the uterine endometrium (B) on various days (D) of pregnancy. Nuclear staining was not observed when irrelevant mouse IgG was substituted for primary antibodies (IgG). ED, Embryonic disc; TE, trophectoderm; LE, luminal epithelium; GE, glandular epithelium; ST, stroma; Magnification, x70 for conceptus and x170 for endometrium. A panel representing D12 conceptus on the top right (A) is shown at higher magnification (x170).

 
Characterization of pTr cells
The epithelial phenotype of pTr cells (Fig. 4AGo) was confirmed based on a cobblestone morphology (a) and by positive cytokeratin (b) and negative vimentin (c) immunostaining compared with the IgG control (d). KGFR, expressed in porcine trophectoderm and endometrial epithelial cells (4), and IFN{delta}, expressed by porcine trophectoderm (24), were detected in pTr cells by RT-PCR (Fig. 4Go, B and C).



View larger version (38K):
[in this window]
[in a new window]
 
Figure 4. Characterization of pTr cells. A, Phase contrast microscopy of pTr cells (a). Immunofluorescence analysis of expression of cytokeratin (b), vimentin (c), and the negative control for immunofluorescence (d). RT-PCR analysis of KGFR (B) and IFN{delta} (C) expression by pTr cells is shown when primers specific for 104-bp KGFR and 296-bp IFN{delta} were used for PCR amplification. Note that pTr cells express KGFR and IFN{delta}, which are porcine trophectoderm markers. D15E, Day 15 endometrium; D85FS, day 85 fetal skin; No RNA, no total RNA; No RT, no reverse transcriptase; D12Conc, day 12 conceptus.

 
Effect of KGF on pTr cell proliferation
DNA synthesis by pTr cells, as measured by [3H]thymidine incorporation, increased (quadratic, P < 0.01) in response to treatment with increasing doses of rKGF (Fig. 5AGo).



View larger version (21K):
[in this window]
[in a new window]
 
Figure 5. Effect of KGF on pTr cell proliferation, KGFR activation, and the MAPK signaling pathway. A, Effect of KGF on [3H]thymidine incorporation in pTr cells. rKGF increased [3H]thymidine incorporation in a dose-dependent manner in pTr cells (quadratic, P < 0.01). B, Activation of KGFR phosphorylation by KGF treatment. pTr cells were treated with rKGF (10 ng/ml) for 0, 10, 20, 30, and 60 min, and 1 mg of each cell lysate was immunoprecipitated with 5 µg KGFR antibody. A duplicate 30 min point was immunoprecipitated with 5 µg normal rabbit IgG. Immunoprecipitated proteins were analyzed by Western blotting using anti-phosphotyrosine. C, Activation of ERK1/2 phosphorylation by KGF treatment between 0 and 20 min. pTr cells were treated with rKGF (10 ng/ml) for 0, 10, 20, 30, 60, 120, or 240 min, and 20 µg of each cell lysate were separated by SDS-PAGE and analyzed for ERK1/2 and phosphorylated ERK1/2 (pERK1/2) by Western blotting. D, Inhibition of KGF effect on ERK1/2 phosphorylation by PD98059, a MEK1 inhibitor, is demonstrated. pTr cells were pretreated with PD98059 (0 or 50 µM) for 60 min and treated with rKGF (0 or10 ng/ml) for 60 min, and 20 µg of each cell lysate was separated by SDS-PAGE and analyzed for ERK1/2 and pERK1/2 by Western blotting.

 
Phosphorylation of KGFR and MAPK by KGF
Treatment of pTr cells with rKGF resulted in phosphorylation of KGFR and ERK1/2 within 10 min, and phosphorylation of ERK1/2 was maintained up to 4 h (Fig. 5Go, B and C). Pretreatment of cells with PD98059, a MEK1 inhibitor, blocked the ability of rKGF to induce phosphorylation of ERK1/2 (Fig. 5DGo).

Effect of KGF on pTr cell differentiation
The specificity of the bovine uPA probe was confirmed by Northern blot analysis of total RNA from pTr cells, and a single transcript of about 2.5 kb was detected (Fig. 6AGo). Treatment of pTr cells with increasing doses of rKGF increased (quadratic, P < 0.01) the expression of uPA (Fig. 6BGo).



View larger version (22K):
[in this window]
[in a new window]
 
Figure 6. Effect of KGF on expression of uPA, a marker for pTr cell differentiation. Northern (A) and slot blot (B) analyses of uPA expression. A single transcript of uPA (~2.5 kb) was detected (A), and KGF increased uPA expression (B) in a dose-dependent manner in pTr cells (quadratic, P < 0.01).

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Synthesis and secretion of estrogens by conceptuses have been reported for many species, including pigs, ruminants, and horses (25). However, the ability to synthesize estrogens is especially significant for pig conceptuses, because these estrogens are responsible for maternal recognition of pregnancy as well as stimulation of uterine secretory activity (11, 25, 26). The results of the present study indicate that KGF expression is up-regulated by E2 and are consistent with recent reports that estrogen increases KGF expression (9, 10). In mouse mammary gland, E2 treatment in vivo increased the expression of KGF mRNA and protein in both peripubertal and mature mice (10).

Catechol estrogens, 2OH-E2 and 4OH-E2, are secreted by porcine conceptuses on days 12 and 13 (27), but did not affect KGF expression in porcine endometrium in the present study. This may be due to the low affinity of catechol estrogens for the ER compared with E2 (28, 29) or perhaps the inherent instability of catechol estrogens. It should be noted that various forms of estrogens are present in the porcine uterine lumen during pregnancy, such as estrone, estradiol, estriol, catechol estrogens, and their sulfated forms (27, 30, 31). Levels of estradiol in the uterine lumen of pregnant pigs (~4.3 nM) are significantly higher than those in nonpregnant pigs (~0.26 nM) between days 9 and 15, and E2 predominates over all other estrogens in the uterine lumen (30). Therefore, it is likely that E2 is the predominant estrogen that acts via ER{alpha} to increase endometrial KGF expression in the pregnant pig uterus. It remains to be determined whether ERß is expressed in the porcine uterine endometrium.

E2 probably up-regulates KGF mRNA expression in endometrial epithelial cells through direct interaction with ER present in these cells. ER{alpha} protein is localized to LE and GE cells of the porcine endometrium (32), and up-regulation of KGF expression by E2 is inhibited by the ER antagonist, ICI 182,780. Indeed, the promoter region of the human KGF gene contains an estrogen response element (33). ER{alpha} expression in endometrial epithelial cells during early pregnancy is unique in the pig uterus compared with other species, such as sheep and primates, in which the endometrial epithelial cells do not express ER{alpha} during the P4-dominant period (16, 34). In pigs, ER{alpha} staining in LE and GE is readily detectable from days 5–12 of the estrous cycle and pregnancy, then decreases, but remains detectable until day 15 of the estrous cycle and pregnancy. ER{alpha} is absent in stromal cells between days 5 and 15 of the estrous cycle and pregnancy (32).

P4 is the major hormone responsible for the establishment and maintenance of pregnancy. During diestrus and early pregnancy, production of P4 by the corpus luteum begins to increase (12) and is associated with significant increases in uterine secretory activity (13). P4 treatment in the primate uterus increases KGF expression (8). However, the results of the present study indicated that P4 decreased KGF expression in porcine endometrium. The mechanism of the P4-mediated decrease in KGF expression is not known. Interestingly, E2 increased KGF expression in the presence of P4, a situation to which the endometrial epithelium would be exposed in vivo during pregnancy. As P4 down-regulates endometrial ER{alpha} in ovine uterus (16, 35, 36), the decreased expression of KGF in endometrial explants treated with P4 alone and E2 plus P4 may be the result of a P4-mediated decrease in ER and an attenuated response to E2. We cannot rule out the effects of any residual levels of estradiol on decreased KGF expression by P4 in this system. It is also possible that P4 inhibits KGF expression through a direct mechanism or indirectly by modulation of other unknown factors which then down-regulate KGF expression.

KGF affects epithelial cell proliferation in various tissues (37). In the present study KGF increased DNA synthesis of pTr cells, which are of epithelial cell origin and express KGFR, and IFN{delta}, a porcine trophectoderm cell-specific marker (24). Porcine conceptuses undergo dramatic morphological changes during early pregnancy (13, 14). Between days 10 and 12 of pregnancy there is a rapid transition from spherical (9–10 mm in diameter) to tubular (10–50 mm in length) and elongated filamentous forms (>100 mm long) (14). In the present study trophectoderm cell proliferation was detected between days 9 and 15 of conceptus development as reported previously (14). Thus, in vitro results of the present study suggest that KGF of endometrial epithelial origin may increase the proliferation of conceptus trophectoderm during the periimplantation phase of development. This hypothesis is supported by results from PCNA staining of conceptuses in vivo between days 9–15 of pregnancy, indicating high intensity PCNA staining from day 10 of pregnancy and thereafter. The PCNA staining in the conceptuses is coordinate with increasing KGF expression in the endometrium between days 10 and 15 of pregnancy (4). The lack of detection of PCNA in the LE and GE during early pregnancy suggests that epithelial cells do not proliferate to any great degree at this time. Therefore, although KGF is present in the uterine lumen, and KGFR is expressed in LE and GE, it is unlikely that KGF affects epithelial cell proliferation in the endometrium during early pregnancy. However, it is possible that KGF affects differentiation of endometrial epithelial cells.

In addition to effecting proliferation, KGF was found to alter conceptus trophectoderm cell differentiation in this study. In various cell types, uPA, aromatase, surfactant protein A and D, syndecan-1, and Na+/K+-adenosine triphosphatase are increased by KGF (1, 37, 38). In particular, KGF increases uPA expression and activity in human uterine exocervical epithelial cells (39) and keratinocytes (40). In this study KGF increased uPA expression in pTr cells. Differentiating pig conceptuses produce uPA from trophoblast (41), and pig conceptus trophectoderm produces uPA in a biphasic manner between days 10 and 12 and between days 14 and 16 of early pregnancy (42), coinciding with estrogen production by conceptuses. Therefore, increased expression of uPA by KGF in pTr cells suggests that KGF expression increases within endometrial LE in response to estrogen, is secreted into the uterine lumen, and may be an important regulator of uPA secretion by conceptus trophectoderm.

Like most receptor tyrosine kinase-activating growth factors, KGFR signals through the MAPK pathway (15). In the present study phosphorylation of KGFR and ERK1/2, members of the MAPK family, was detected in KGF-treated pTr cells, suggesting that effects on trophectoderm proliferation and differentiation were mediated by interaction of KGF with the KGFR. Among the several FGFR isoforms, KGF recognizes only KGFR with high affinity and biological activity (43), precluding the possibility that ERK1/2 is activated by other members of the FGFR family. The precise mechanisms of intracellular KGF signaling for proliferation and differentiation in pTr cells remain to be determined.

In summary, the results of the present study indicate that E2, a pregnancy recognition signal in pigs, increases KGF expression in the uterine endometrium, and that KGF increases the proliferation of conceptus trophectoderm and stimulates the expression of uPA, a marker for differentiation. Thus, KGF of endometrial origin affects both the growth and differentiation of trophectoderm during this crucial phase of conceptus development in pigs.


    Acknowledgments
 
The authors thank Dr. Robert C. Burghardt for assistance with immunofluorescence image capture and use of microscopy and imaging facilities in the Image Analysis Laboratory of College of Veterinary Medicine. We also thank Dr. Wallace L. McKeehan for providing recombinant rat KGF.


    Footnotes
 
1 This work was supported by USDA Grant NRICGP 2000–02290 (to F.W.B. and L.A.J.) and NIH Grant P30-ES-09106 (to Image Analysis Laboratory of College of Veterinary Medicine). Back

2 Present address: Department of Animal and Veterinary Science, University of Idaho, Moscow, Idaho 83844-2330. Back

Received January 8, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Rubin JS, Bottaro DP, Chedid M, Miki T, Ron D, Cheon HG, Taylor WG, Fortney E, Sakata H, Finch PW, LaRochelle WJ 1995 Keratinocyte growth factor. Cell Biol Int 19:399–411[CrossRef][Medline]
  2. Cooke PS, Buchanan DL, Kurita T, Lubahn DB, Cunha GR 1998 Stromal-epithelial cell communication in the female reproductive tract. In: Bazer FW (ed) The Endocrinology of Pregnancy, chapt 17. Humana Press, Totowa, pp 491–506
  3. Chen C, Spencer TE, Bazer FW 2000 Fibroblast growth factor-10: a stromal mediator of epithelial function in the ovine uterus. Biol Reprod 63:959–966[Abstract/Free Full Text]
  4. Ka H, Spencer TE, Johnson GA, Bazer FW 2000 Keratinocyte growth factor: expression by endometrial epithelia of the porcine uterus. Biol Reprod 62:1772–1778[Abstract/Free Full Text]
  5. Fasciana C, van der Made AC, Faber PW, Trapman J 1996 Androgen regulation of the rat keratinocyte growth factor (KGF/FGF7) promoter. Biochem Biophys Res Commun 220:858–863[CrossRef][Medline]
  6. Yan G, Fukabori Y, Nikolaropoulos S, Wang F, McKeehan WL 1992 Heparin-binding keratinocyte growth factor is a candidate stromal to epithelial cell andromedin. Mol Endocrinol 6:2123–2128[Abstract]
  7. Alarid ET, Rubin JS, Young P, Chedid M, Ron D, Aaronson SA, Cunha GR 1994 Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc Natl Acad Sci USA 91:1074–1078[Abstract/Free Full Text]
  8. Koji T, Chedid M, Rubin JS, Slayden OD, Csaky KG, Aaronson SA, Brenner RM 1994 Progesterone-dependent expression of keratinocyte growth factor mRNA in stromal cells of the primate endometrium: keratinocyte growth factor as a progestomedin. J Cell Biol 125:393–401[Abstract/Free Full Text]
  9. Hom YK, Young P, Thomson AA, Cunha GR 1998 Keratinocyte growth factor injected into female mouse neonates stimulates uterine and vaginal epithelial growth. Endocrinology 139:3772–3779[Abstract/Free Full Text]
  10. Pedchenko VK, Imagawa W 2000 Estrogen treatment in vivo increases keratinocyte growth factor expression in the mammary gland. J Endocrinol 165:39–49[Abstract]
  11. Bazer FW, Ott TL, Spencer TE 1998 Endocrinology of the transition from recurring estrous cycles to establishment of pregnancy in subprimate mammals. In: Bazer FW (ed) The Endocrinology of Pregnancy, chapt 1. Humana Press, Totowa, pp 1–34
  12. Guthrie HD, Henricks DM, Handlin DL 1972 Plasma estrogen, progesterone, and luteinizing hormone prior to estrus and during pregnancy in pigs. Endocrinology 91:675–679[Medline]
  13. Roberts RM, Bazer FW 1988 The functions of uterine secretions. J Reprod Fertil 82:875–892[CrossRef][Medline]
  14. Geisert RD, Brookbank JW, Roberts RM, Bazer FW 1982 Establishment of pregnancy in the pig. II. Cellular remodeling of the porcine blastocyst during elongation on day 12 of pregnancy. Biol Reprod 27:941–955[CrossRef][Medline]
  15. Szebenyi G, Fallon JF 1999 Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytol 185:45–106[Medline]
  16. Spencer TE, Bazer FW 1995 Temporal and spatial alterations in uterine estrogen receptor and progesterone receptor gene expression during the estrous cycle and early pregnancy in the ewe. Biol Reprod 53:1527–1543[Abstract]
  17. Johnson GA, Spencer TE, Hansen TR, Austin KJ, Burghardt RC, Bazer FW 1999 Expression of the interferon tau inducible ubiquitin cross-reactive protein in the ovine uterus. Biol Reprod 61:312–318[Abstract/Free Full Text]
  18. Corps AN, Brigstock DR, Littlewood CJ, Brown KD 1990 Receptors for epidermal growth factor and insulin-like growth factor I on preimplantation trophectoderm of the pig. Development 110:221–227[Abstract]
  19. Gupta A, Dekaney CM, Bazer FW, Madrigal MM, Jaeger LA 1998 ß Transforming growth factors (TGFß) at the porcine conceptus-maternal interface. II. Uterine TGFß bioactivity and expression of immunoreactive TGFßs (TGFß1, TGFß2, and TGFß3) and their receptors (type I and type II). Biol Reprod 59:911–917[Abstract/Free Full Text]
  20. Taylor KM, Gray CA, Joyce MM, Stewart MD, Bazer FW, Spencer TE 2000 Neonatal ovine uterine development involves alterations in expression of receptors for estrogen, progesterone, and prolactin. Biol Reprod 63:1192–1204[Abstract/Free Full Text]
  21. Johnson GA, Burghardt RC, Newton GR, Bazer FW, Spencer TE 1999 Development and characterization of immortalized ovine endometrial cell lines. Biol Reprod 61:1324–1330[Abstract/Free Full Text]
  22. Stewart MD, Johnson GA, Vyhlidal CA, Burghardt RC, Safe SH, Yu-Lee LY, Bazer FW, Spencer TE 2000 Interferon tau activates multiple STAT proteins and has complex effects on interferon-responsive gene transcription in endometrial epithelial cells. Endocrinology 142:98–107[Abstract/Free Full Text]
  23. SAS Institute 1990 SAS User’s Guide: Statistics, version 6. SAS Institute, Cary
  24. Lefevre F, Guillomot M, D’Andrea S, Battegay S, La Bonnardiere C 1998 Interferon-{delta}: the first member of a novel type I interferon family. Biochimie 80:779–788[Medline]
  25. Heap RB, Flint AFP, Staple LD 1983 Endocrinology of trophoblast in farm animals. In: Loke YW, Whyte A (eds) Biology of Trophoblast. Elsevier, New York, pp 353–400
  26. Geisert RD, Zavy MT, Wettemann RP, Biggers BG 1987 Length of pseudopregnancy and pattern of uterine protein release as influenced by time and duration of oestrogen administration in the pig. J Reprod Fertil 79:163–172[Abstract/Free Full Text]
  27. Mondschein JS, Hersey RM, Dey SK, Davis DL, Weisz J 1985 Catechol estrogen formation by pig blastocysts during the preimplantation period: biochemical characterization of estrogen-2/4-hydroxylase and correlation with aromatase activity. Endocrinology 117:2339–2346[Abstract]
  28. Martucci C, Fishman J 1976 Uterine estrogen receptor binding of catechol estrogens and of estetrol (1,3,5(10)-estratriene-3,15{alpha},16[alpha,17beta]-tetrol). Steroids 27:325–333[CrossRef][Medline]
  29. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors {alpha} and ß. Endocrinology 138:863–870[Abstract/Free Full Text]
  30. Stone BA, Seamark RF 1985 Steroid hormones in uterine washings and in plasma of gilts between days 9 and 15 after oestrus and between days 9 and 15 after coitus. J Reprod Fertil 75:209–221[Abstract/Free Full Text]
  31. Geisert RD, Renegar RH, Thatcher WW, Roberts RM, Bazer FW 1982 Establishment of pregnancy in the pig. I. Interrelationships between preimplantation development of the pig blastocyst and uterine endometrial secretions. Biol Reprod 27:925–939[CrossRef][Medline]
  32. Geisert RD, Brenner RM, Moffatt RJ, Harney JP, Yellin T, Bazer FW 1993 Changes in oestrogen receptor protein, mRNA expression and localization in the endometrium of cyclic and pregnant gilts. Reprod Fertil Dev 5:247–260[CrossRef][Medline]
  33. Finch PW, Lengel C, Chedid M 1995 Cloning and characterization of the promoter region of the human keratinocyte growth factor gene. J Biol Chem 270:11230–11237[Abstract/Free Full Text]
  34. Brenner RM, West NB, McClellan MC 1990 Estrogen and progestin receptors in the reproductive tract of male and female primates. Biol Reprod 42:11–19[Abstract]
  35. Spencer TE, Mirando MA, Watson GH, Ott TL, Bazer FW 1996 Effects of interferon-{tau} and progesterone on estrogen-stimulated expression of receptors for estrogen, progesterone and oxytocin in the endometrium of ovariectomized ewes. Reprod Fertil Dev 8:843–853[CrossRef][Medline]
  36. Spencer TE, Gray A, Johnson GA, Taylor KM, Gertler A, Gootwine E, Ott TL, Bazer FW 1999 Effects of recombinant ovine interferon tau, placental lactogen, and growth hormone on the ovine uterus. Biol Reprod 61:1409–1418[Abstract/Free Full Text]
  37. Werner S 1998 Keratinocyte growth factor: a unique player in epithelial repair processes. Cytokine Growth Factor Rev 9:153–165[CrossRef][Medline]
  38. Maatta A, Jaakkola P, Jalkanen M 1999 Extracellular matrix-dependent activation of syndecan-1 expression in keratinocyte growth factor-treated keratinocytes. J Biol Chem 274:9891–9898[Abstract/Free Full Text]
  39. Zheng J, Siren V, Vaheri A 1996 Keratinocyte growth factor enhances urokinase-type plasminogen activator activity in HPV16 DNA-immortalized human uterine exocervical epithelial cells. Eur J Cell Biol 69:128–134[Medline]
  40. Tsuboi R, Sato C, Kurita Y, Ron D, Rubin JS, Ogawa H 1993 Keratinocyte growth factor (FGF-7) stimulates migration and plasminogen activator activity of normal human keratinocytes. J Invest Dermatol 101:49–53[CrossRef][Medline]
  41. Strickland S, Reich E, Sherman MI 1976 Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm. Cell 9:231–240[CrossRef][Medline]
  42. Fazleabas AT, Geisert RD, Bazer FW, Roberts RM 1983 Relationship between release of plasminogen activator and estrogen by blastocysts and secretion of plasmin inhibitor by uterine endometrium in the pregnant pig. Biol Reprod 29:225–238[Abstract]
  43. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M 1996 Receptor specificity of the fibroblast growth factor family. J Biol Chem 271:15292–15297[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
EndocrinologyHome page
H. Seo, M. Kim, Y. Choi, C.-K. Lee, and H. Ka
Analysis of Lysophosphatidic Acid (LPA) Receptor and LPA-Induced Endometrial Prostaglandin-Endoperoxide Synthase 2 Expression in the Porcine Uterus
Endocrinology, December 1, 2008; 149(12): 6166 - 6175.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. M. Joyce, R. C. Burghardt, R. D. Geisert, J. R. Burghardt, R. N. Hooper, J. W. Ross, M. D. Ashworth, and G. A. Johnson
Pig Conceptuses Secrete Estrogen and Interferons to Differentially Regulate Uterine STAT1 in a Temporal and Cell Type-Specific Manner
Endocrinology, September 1, 2007; 148(9): 4420 - 4431.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H. Ka, S. Al-Ramadan, D. W. Erikson, G. A. Johnson, R. C. Burghardt, T. E. Spencer, L. A. Jaeger, and F. W. Bazer
Regulation of Expression of Fibroblast Growth Factor 7 in the Pig Uterus by Progesterone and Estradiol
Biol Reprod, July 1, 2007; 77(1): 172 - 180.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. D. Michael, I. M. Alvarez, O. M. Ocon, A. M. Powell, N. C. Talbot, S. E. Johnson, and A. D. Ealy
Fibroblast Growth Factor-2 Is Expressed by the Bovine Uterus and Stimulates Interferon-{tau} Production in Bovine Trophectoderm
Endocrinology, July 1, 2006; 147(7): 3571 - 3579.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. A. Jaeger, A. K. Spiegel, N. H. Ing, G. A. Johnson, F. W. Bazer, and R. C. Burghardt
Functional Effects of Transforming Growth Factor {beta} on Adhesive Properties of Porcine Trophectoderm
Endocrinology, September 1, 2005; 146(9): 3933 - 3942.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
G. A. Johnson, R. C. Burghardt, M. M. Joyce, T. E. Spencer, F. W. Bazer, C. Pfarrer, and C. A. Gray
Osteopontin Expression in Uterine Stroma Indicates a Decidualization-Like Differentiation During Ovine Pregnancy
Biol Reprod, June 1, 2003; 68(6): 1951 - 1958.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
B. J. Tarleton, T. D. Braden, A. A. Wiley, and F. F. Bartol
Estrogen-Induced Disruption of Neonatal Porcine Uterine Development Alters Adult Uterine Function
Biol Reprod, April 1, 2003; 68(4): 1387 - 1393.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Taniguchi, T. Harada, Y. Sakamoto, N. Yamauchi, S. Yoshida, T. Iwabe, and N. Terakawa
Activation of Mitogen-Activated Protein Kinase Pathway by Keratinocyte Growth Factor or Fibroblast Growth Factor-10 Promotes Cell Proliferation in Human Endometrial Carcinoma Cells
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 773 - 780.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. E. Garlow, H. Ka, G. A. Johnson, R. C. Burghardt, L. A. Jaeger, and F. W. Bazer
Analysis of Osteopontin at the Maternal-Placental Interface in Pigs
Biol Reprod, March 1, 2002; 66(3): 718 - 725.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. A. Kowalski, L. G. Graddy, D. S. Vale-Cruz, I. Choi, B. S. Katzenellenbogen, F. A. Simmen, and R. C.M. Simmen
Molecular Cloning of Porcine Estrogen Receptor-{beta} Complementary DNAs and Developmental Expression in Periimplantation Embryos
Biol Reprod, March 1, 2002; 66(3): 760 - 769.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ka, H.
Right arrow Articles by Bazer, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ka, H.
Right arrow Articles by Bazer, F. W.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals